Cutaneous erosions: a herald for impending pancytopenia in methotrexate toxicity
General Material Designation
[Article]
First Statement of Responsibility
Shiver, Mallory B; Hall, Lauren A; Conner, Kelly B; Brown, Grace E; Cheung, Wang L; Wirges, Marla L
SUMMARY OR ABSTRACT
Text of Note
Psoriatic plaque erosion is a rare toxic side effect of low-dose methotrexate (LDMTX) that has been reported during the treatment of psoriasis and described as a herald for impending pancytopenia. Fatalities from this have rarely been reported. Even rarer is methotrexate (MTX)-induced erosions of clinically normal skin in patients without a history of psoriasis. We report 3 rare presentations of MTX-induced cutaneous erosions, 2 fatalities occurring with MTX-induced psoriatic plaque erosions, and the sixth reported case of MTX-induced erosions with no prior history of psoriasis. Each were elderly patients on proton pump inhibitors with a history of chronic non-steroidal anti-inflammatory drug (NSAID) use. They all presented with acute onset of erosions after a recent change in their MTX dose. Pancytopenia followed in each case. Physicians' awareness of the sequelae in MTX-induced cutaneous erosions is imperative so MTX can be discontinued and treatment instituted to prevent fatal bone marrow suppression.
SET
Date of Publication
2014
Title
Dermatology Online Journal
Volume Number
20/7
PERSONAL NAME - PRIMARY RESPONSIBILITY
Entry Element
Shiver, Mallory B; Hall, Lauren A; Conner, Kelly B; Brown, Grace E; Cheung, Wang L; Wirges, Marla L